PT-2021-8570 · Bmc · Bmc Remedy Mid Tier

Kristian Varnai + 1 · Published 2021-05-19 · Updated 2021-06-01 · CVE-2017-17678

Positive Technologies (AI Summary)

CVSS v3.1

6.1

Medium

Base vector

AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Name of the Vulnerable Software and Affected Versions BMC Remedy Mid Tier version 9.1SP3

Description A DOM-based cross-site scripting issue was found in a legacy utility of the software, which can be exploited for cross-site scripting (XSS) attacks.

Recommendations For version 9.1SP3, consider disabling the legacy utility as a temporary workaround until a patch is available. Restrict access to potentially vulnerable components to minimize the risk of exploitation.

Fix

XSS

Weakness Enumeration

CWE-79

Related Identifiers

CVE-2017-17678

Affected Products

Bmc Remedy Mid Tier

References · 8

• https://nvd.nist.gov/vuln/detail/CVE-2017-17678 · Security Note
• https://osv.dev/vulnerability/CVE-2017-17678 · Vendor Advisory
• https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html · Vendor Advisory
• http://bmc.com · Note
• http://remedy.com · Note
• https://t.me/cvenotify/14649 · Telegram Post
• https://t.me/cvenotify/15345 · Telegram Post
• https://seclists.org/fulldisclosure/2017/Oct/52 · Note